8-KShareholder MattersCorporate ChangesExhibits & Filings

DEXCOM INC 8-K Report, Bylaw Amendment (May 21, 2021)

Filed May 21, 2021For Securities:DXCM

Summary

This 8-K filing by DexCom, Inc. (DXCM) on May 21, 2021, primarily announces significant changes to the company's corporate governance structure. The most impactful event for investors is the filing of a restated certificate of incorporation to declassify the Board of Directors over a three-year period, starting at the 2022 annual meeting. This move aims to bring DexCom in line with common corporate governance practices and generally enhances shareholder influence by allowing for the annual election of all directors. Furthermore, the filing details the outcomes of DexCom's Annual Stockholders' Meeting. Key votes approved include the election of three Class I directors, the ratification of Ernst & Young LLP as the independent registered public accounting firm for fiscal year 2021, advisory approval of executive compensation, and crucially, the approval of the amendment to declassify the Board of Directors. These shareholder approvals signal strong support for the company's direction and governance changes.

Key Highlights

  • 1DexCom filed a restated certificate of incorporation to declassify its Board of Directors over a three-year period starting in 2022.
  • 2The Board's bylaws were also amended and restated to reflect the declassification and implement proxy access procedures.
  • 3Shareholders elected three Class I directors, with Kevin R. Sayer, Nicholas Augustinos, and Bridgette P. Heller continuing their terms.
  • 4The appointment of Ernst & Young LLP as the independent registered public accounting firm for fiscal year 2021 was ratified by shareholders.
  • 5An advisory resolution on executive compensation received shareholder approval.
  • 6Shareholders voted overwhelmingly in favor of declassifying the Board of Directors.
  • 7The changes to the certificate of incorporation and bylaws became effective upon filing with the Secretary of State of Delaware on May 21, 2021.

Frequently Asked Questions

Declassifying the Board of Directors means that all directors will be elected annually by shareholders. Previously, the Board was classified (or staggered), meaning only a portion of directors were up for election each year. This change allows shareholders to vote on the election of all directors at each annual meeting, increasing direct accountability.

The declassification process will occur over a three-year period, beginning at the 2022 annual meeting of shareholders. This phased approach allows for a gradual transition to annual elections for all board seats.

Proxy access is a provision that allows long-term shareholders to nominate their own candidates for the Board of Directors on the company's proxy materials. Implementing proxy access empowers shareholders and provides them with a more direct mechanism to nominate directors who they believe will better represent their interests.

Shareholders voted on an advisory resolution regarding compensation paid to DexCom's named executive officers. The vote passed, with a significant majority of shares voting in favor, indicating shareholder support for the company's executive compensation practices as disclosed.